BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 17449065)

  • 1. Small molecule intercalation with double stranded DNA: implications for normal gene regulation and for predicting the biological efficacy and genotoxicity of drugs and other chemicals.
    Hendry LB; Mahesh VB; Bransome ED; Ewing DE
    Mutat Res; 2007 Oct; 623(1-2):53-71. PubMed ID: 17449065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of N-dialkyl and other cationic substituents on DNA intercalation and genotoxicity.
    Snyder RD; McNulty J; Zairov G; Ewing DE; Hendry LB
    Mutat Res; 2005 Oct; 578(1-2):88-99. PubMed ID: 15990125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of atypical DNA intercalating agents in biological and in silico systems.
    Snyder RD
    Mutat Res; 2007 Oct; 623(1-2):72-82. PubMed ID: 17434187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity of non-covalent interactions: DNA intercalators.
    Ferguson LR; Denny WA
    Mutat Res; 2007 Oct; 623(1-2):14-23. PubMed ID: 17498749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.
    Palchaudhuri R; Hergenrother PJ
    Curr Opin Biotechnol; 2007 Dec; 18(6):497-503. PubMed ID: 17988854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a greater appreciation of noncovalent chemical/DNA interactions: application of biological and computational approaches.
    Snyder RD; Hendry LB
    Environ Mol Mutagen; 2005; 45(2-3):100-5. PubMed ID: 15668940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug discovery and molecular biological methods, via DNA, RNA and protein changes using structure-function transitions: Transitional structural chemogenomics, transitional structural chemoproteomics and novel multi-stranded nucleic acid microarray.
    Gagna CE; Lambert WC
    Med Hypotheses; 2006; 67(5):1099-114. PubMed ID: 16828979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DNA intercalation potential of pharmaceuticals and other chemicals by cell-based and three-dimensional computational approaches.
    Snyder RD; Ewing DE; Hendry LB
    Environ Mol Mutagen; 2004; 44(2):163-73. PubMed ID: 15278920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial translational motions of base pairs in DNA molecules: application of the extended matrix generator method.
    Marky NL; Olson WK
    Biopolymers; 1994 Jan; 34(1):121-42. PubMed ID: 8110965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the molecular mechanism of drug intercalation into DNA: a simulation study of the intercalation pathway, free energy, and DNA structural changes.
    Mukherjee A; Lavery R; Bagchi B; Hynes JT
    J Am Chem Soc; 2008 Jul; 130(30):9747-55. PubMed ID: 18611009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a macrocyclic bisacridine and ametantrone to CGTACG involves similar unusual intercalation platforms.
    Yang XL; Robinson H; Gao YG; Wang AH
    Biochemistry; 2000 Sep; 39(36):10950-7. PubMed ID: 10998231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification.
    Wilson WD; Tanious FA; Barton HJ; Wydra RL; Jones RL; Boykin DW; Strekowski L
    Anticancer Drug Des; 1990 Feb; 5(1):31-42. PubMed ID: 1690546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A theory of mode of action of azolylalkylquinolines as DNA binding agents using automated flexible ligand docking.
    Sobhani AM; Amini SR; Tyndall JD; Azizi E; Daneshtalab M; Khalaj A
    J Mol Graph Model; 2006 Dec; 25(4):459-69. PubMed ID: 16621634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing DNA intercalation.
    Persil O; Hud NV
    Trends Biotechnol; 2007 Oct; 25(10):433-6. PubMed ID: 17825446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncovalent interactions with DNA: an overview.
    Strekowski L; Wilson B
    Mutat Res; 2007 Oct; 623(1-2):3-13. PubMed ID: 17445837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of a DNA-threading netropsin-amsacrine combilexin with DNA and chromatin.
    Bourdouxhe-Housiaux C; Colson P; Houssier C; Waring MJ; Bailly C
    Biochemistry; 1996 Apr; 35(14):4251-64. PubMed ID: 8605173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambivalent intercalators for DNA: L-shaped platinum(II) complexes.
    Cusumano M; Di Pietro ML; Giannetto A; Nicolò F; Nordén B; Lincoln P
    Inorg Chem; 2004 Apr; 43(7):2416-21. PubMed ID: 15046518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking studies on DNA intercalators.
    Gilad Y; Senderowitz H
    J Chem Inf Model; 2014 Jan; 54(1):96-107. PubMed ID: 24303988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
    Faddeeva MD; Beliaeva TN
    Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.